Shigeki Miyake Stoner
About Shigeki Miyake Stoner
Shigeki Miyake Stoner serves as the Director of R&D and Head of Technology at Replicate Bioscience, where he leads efforts in RNA vaccines and therapeutics. He has extensive experience in genomic engineering and has previously held positions at Viridos, Synthetic Genomics, and the Salk Institute for Biological Studies.
Current Role at Replicate Bioscience
Shigeki Miyake Stoner serves as the Director of R&D and Head of Technology at Replicate Bioscience, Inc. since 2021. In this role, he leads research and development efforts aimed at advancing next-generation RNA vaccines and therapeutics for clinical applications. His leadership focuses on integrating innovative technologies into the company's pipeline, enhancing the potential for effective treatments.
Previous Experience in Genomic Engineering
Prior to his current position, Shigeki worked at Viridos, where he broadened his work towards genomic engineering of algae. His efforts aimed to mature technology for applications in biofuels. He also developed self-replicating RNA replicon therapeutic vectors and vaccines, which led to licensing agreements with partners in human and animal health.
Educational Background
Shigeki Miyake Stoner completed his undergraduate studies at Franklin & Marshall College, earning Bachelor's Degrees in Chemistry, Biochemistry, and Molecular Biology from 2005 to 2009. He later pursued a Doctor of Philosophy (PhD) in Biology at UC San Diego, completing his studies from 2009 to 2017. His academic foundation supports his extensive work in biotechnology and R&D.
Research and Development Contributions
Shigeki has a history of impactful contributions in research and development. At Synthetic Genomics, he worked as Scientist II in Algae Strain Engineering, where he developed strategies for altering adenovirus tropism. His research at the Salk Institute for Biological Studies as a Translational Scientist involved manipulating virus genes that interact with the Rb tumor-suppressor pathway, enhancing the understanding of viral interactions in therapeutic contexts.
Consultation and Expertise in Biotech R&D
Shigeki provides consultation in life biotech R&D, specializing in nucleic acid vectors, adenovirus, and other viral vectors for drug discovery and therapeutic development. His expertise encompasses a broad range of applications, contributing to advancements in the field of biotechnology and therapeutic innovations.